This is a paid press release. Contact the press release distributor directly with any inquiries.

Field Trip Health Ltd. to Participate in Upcoming Conferences in November 2021

Field Trip Health, Ltd.

November 3, 2021 4 min read

FTRP

TORONTO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that during the month of November management will attend the Microdose Wonderland: Miami Conference and present at the Stifel 2021 Virtual Healthcare Conference and the Jefferies London Healthcare Conference.

Wonderland: Miami Conference
Field Trip’s Co-founder and Executive Chairman, Ronan Levy will attend the Microdose Wonderland: Miami conference taking place between November 8-9, 2021 to be held at the Adrienne Arsht Center for the Performing Arts in Miami, FL.

Stifel 2021 Virtual Healthcare Conference
Field Trip’s Co-founder and Executive Chairman, Ronan Levy, and Field Trip’s Chief Scientific Officer, Dr. Nathan Bryson, will present live at the Stifel Virtual Healthcare Conference at 8:00am ET on Wednesday, November 17, 2021. The presentation will be webcast and available through this link: https://wsw.com/webcast/stifel58/ftrp/2118960.

Jefferies London Healthcare Conference
Field Trip’s management team will present virtually at the Jefferies London Healthcare Conference, taking place on November 18-19. The webcast will be available to registered attendees on-demand, beginning on Thursday, November 18, 2021 at 3:00am ET through Friday, November 19, 2021 at 12:00pm ET. To view the webcast, please visit this link: https://wsw.meetmax.com/admin/presenterlinks/?&group=TbkBHEif.

Field Trip’s management team will be available for one-on-one meetings throughout the duration of the conferences. To schedule a meeting with Field Trip’s management team, please contact KCSA Strategic Communications at fieldtripIR@kcsa.com.

About Field Trip Health Ltd.

Field Trip is a global leader in the development and delivery of psychedelic therapies. With our Field Trip Discovery division leading the development of the next generation of psychedelic molecules and conducting advanced research on plant-based psychedelics and our Field Trip Health division building centers for psychedelic therapies opening across North America and Europe along with the digital and technological tools that will enable massive scale, we help people in need with a simple, evidence-based way to heal and heighten engagement with the world.

Learn more at https://www.meetfieldtrip.com, https://www.fieldtriphealth.com and https://www.fieldtriphealth.nl.

To receive company updates about Field Trip and to be added to the email distribution list please sign up here.

Cautionary Note Regarding Forward-Looking Information

This release includes forward-looking information (within the meaning of Canadian securities laws and within the meaning of the United States Private Securities Litigation Reform Act of 1995) regarding Field Trip and its business. Often but not always, forward-looking information can be identified by the use of words such as "expect", "intends", "anticipated", "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would" or "will" be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of Field Trip and are based on assumptions and subject to risks and uncertainties. Although the management of Field Trip believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies. Although Field Trip has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Field Trip does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Additional information relating to Field Trip, including its Annual Information Form, can be located on the SEDAR website at www.sedar.com and on the EDGAR section of the SEC’s website at www.sec.gov.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities.

Neither the Toronto Stock Exchange, nor its Regulation Services Provider, have approved the contents of this release or accept responsibility for the adequacy or accuracy of this release.

CONTACTS:
Media contacts:
Rachel Moskowitz
Autumn Communications
202-276-7881
press@fieldtriphealth.com

Nick Opich / McKenna Miller
KCSA Strategic Communications
212-896-1206 / 347-487-6197
press@fieldtriphealth.com

Investor contacts:
Kathleen Heaney / Tim Regan
KCSA Strategic Communications
fieldtripIR@kcsa.com

SOURCE Field Trip Health Ltd.